BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201006
DTEND;VALUE=DATE:20201009
DTSTAMP:20260515T122958
CREATED:20200813T124435Z
LAST-MODIFIED:20200813T124843Z
UID:26694-1601942400-1602201599@www.pharmajournalist.com
SUMMARY:The 5th Computational Drug Discovery & Development (CDD) for Biologics Summit
DESCRIPTION:Built with insights from the likes of AbbVie\, Sanofi\, Amgen and Takeda; CDD for Biologics Summit has been specifically designed to help biopharma companies define strategies to further adapt computational tools\, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines. \nThis dedicated platform will enable you to address key challenges such as those of widespread data sharing\, the experimental constraints of generating enough data and the importance of overcoming data silo-ing with organizations\, as well as exploring new opportunities including a novel\, AI-derived approach\, an automated high-throughput engineering platform\, successfully deploying ML algorithms and more. \nAcross 3 days online\, 24 experts will share in-depth their findings on: \n• Leveraging machine learning and computational programs to discover\, design and develop de novo antibodies\n• Model and design structure-based antibody and T cell receptor recognition\n• Computational design of antibodies against spike epitopes of SARS-CoV-2\n• Plug and play application and advantages of computational design\n• Deep dives into computational modeling of immunogenicity prediction\, validation; and opportunities for data availability and sharing \nJoin a diverse faculty of experts this October for the 5th annual gathering to uncover progress made\, and how we can accelerate the adoption of computational tools in the discovery and development of biologics. \nTo know more about CDD for Biologics Summit please click here.
URL:https://www.pharmajournalist.com/event/the-5th-computational-drug-discovery-development-cdd-for-biologics-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201008
DTEND;VALUE=DATE:20201010
DTSTAMP:20260515T122958
CREATED:20200422T100729Z
LAST-MODIFIED:20200422T100729Z
UID:25164-1602115200-1602287999@www.pharmajournalist.com
SUMMARY:2nd Flow Cytometry Congress
DESCRIPTION:As a vital tool for providing quantifiable data on cell characteristics\, flow cytometry is an integral part of diagnostics and the assessment of therapeutic efficacy. Talks will also explore the application of flow cytometry in disease monitoring and diagnosis\, and approaches to implementation in the clinic. \n \nThe meeting will focus on: \n\nAdvances in flow cell and sheath fluid design.\nThe development of new fluorophores.\nNext-generation detection systems\, and\nAn applications session exploring the analysis of cell surface antigens\, reviewing cell health\, cell sorting techniques and\nThe role of flow cytometry in drug development.\n\nWith dedicated space in the schedule to network\, this conference is the ideal forum to share knowledge and build partnerships. This meeting will allow you to keep up to date with the cutting edge of research and the opportunity to further business partnerships with those in your field. \nDelegates will also have access to the co-located Liquid Biopsies Congress and qPCR and Digital PCR Congress. \nVisit the event page to download the full agenda.
URL:https://www.pharmajournalist.com/event/2nd-flow-cytometry-congress/
LOCATION:London\, UK
ORGANIZER;CN="Global Engage Ltd.":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201008
DTEND;VALUE=DATE:20201010
DTSTAMP:20260515T122958
CREATED:20200422T101205Z
LAST-MODIFIED:20200422T101205Z
UID:25169-1602115200-1602287999@www.pharmajournalist.com
SUMMARY:7th QPCR & Digital PCR Congress
DESCRIPTION:qPCR & Digital PCR are the most essential techniques used for quantification of nucleic acid molecules in molecular biology and diagnostics. \nWhere qPCR is considered as a powerful technique that can provide precise and quantitative data reflecting the biology of the tested experimental parameters\, the excellent precision of dPCR supports its application for the detection of rare point mutations and mutations induced by gene editing in a background of wild-type sequences. \n \nAt this congress our expert speaker panel will address these challenges in the form of case studies and interactive sessions. The agenda will focus on the challenges which need to be addressed to successful move forward into clinical studies: \n\nAccuracy\nReproducibility\nAssay optimization\nMultiplexing\nStandardization\nTranslating methods into applications\n\nWith dedicated space in the schedule to network\, this conference is the ideal forum to share knowledge and build partnerships. This meeting will allow you to keep up to date with the cutting edge of research and the opportunity to further business partnerships with those in your field. \nDelegates will also have access to the co-located Flow Cytometry Congress and Liquid Biopsies Congress. \nVisit the event page to download the full agenda.
URL:https://www.pharmajournalist.com/event/7th-qpcr-digital-pcr-congress/
LOCATION:London\, UK
ORGANIZER;CN="Global Engage Ltd.":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201008
DTEND;VALUE=DATE:20201010
DTSTAMP:20260515T122958
CREATED:20200422T101655Z
LAST-MODIFIED:20200422T101655Z
UID:25174-1602115200-1602287999@www.pharmajournalist.com
SUMMARY:2nd Liquid Biopsies Congress
DESCRIPTION:This conference offers experts working in the biopharmaceutical industry as well as academia the opportunity to examine the latest developments in the field with dedicated congress presentations\, panel discussions and roundtables. \n \nThe agenda will explore : \n\nNovel methods\, research techniques\, advances and discoveries in the field.\nResearch applications utilizing technologies such as qPCR\, Digital PCR and NGS.\nThe detection and analysis of on circulating biomarkers such as cell-free DNA\, (cfDNA)\, circulation tumor cells (CTCs)\, and extracellular vesicles (EVs).\nThe growing field of single cell analysis and he use of different fluids for non-invasive testing.\n\nWith dedicated space in the schedule to network\, this conference is the ideal forum to share knowledge and build partnerships. This meeting will allow you to keep up to date with the cutting edge of research and the opportunity to further business partnerships with those in your field. \nDelegates will also have access to the co-located Flow Cytometry Congress and qPCR & Digital PCR Congress. \nVisit the event page to download the full agenda.
URL:https://www.pharmajournalist.com/event/2nd-liquid-biopsies-congress/
LOCATION:London\, UK
ORGANIZER;CN="Global Engage Ltd.":MAILTO:info@globalengage.co.uk
END:VEVENT
END:VCALENDAR